| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |